TOB1 and breast carcinoma: We also used different breast cancer cell lines, SK-BR3 and BT-474, and confirmed that they showed more enhancement of the pIKK-α/β and pIκB-α in Tob knockdown cells than control (Supplementary Fig. 2e, f).